🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Content Elimination

According to the social media company, the platform has taken down problematic content and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at residence.

Within minutes of joining one group, a vendor posted contact information, where the majority of purchases take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Details and Pricing

Inside these communities, messages show black plastic packages with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant health risks”.